Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord

被引:31
作者
Chen, Xue [1 ]
Yang, Yang [1 ,3 ]
Yao, Jian [1 ]
Lin, Weiwei [1 ]
Li, Yi [1 ]
Chen, Ying [1 ]
Gao, Yilu [2 ]
Yang, Yumin
Gu, Xiaosong [3 ]
Wang, Xiaodong [1 ,2 ,3 ]
机构
[1] Nantong Univ, Dept Histol & Embryol, Coll Med, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China
[3] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China
关键词
CHRONIC PARAPLEGIC RATS; MESENCHYMAL STEM-CELLS; IN-VITRO; NERVE REGENERATION; PROGENITOR CELLS; SCHWANN-CELLS; NEURAL STEM; ADULT RATS; TRANSPLANTATION; DIFFERENTIATION;
D O I
10.1007/s10856-011-4401-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this study, a chitosan conduit loaded with bone marrow stromal cells (BMSCs) was developed to bridge the gap in the transected spinal cord of adult rats, and the nerve repair outcomes were evaluated by functional and histological techniques at 12 weeks after implantation. As compared to chitosan conduits alone, incorporation of BMSCs within chitosan conduits yielded additional improving effects on nerve regeneration and function restoration. The measurements with the Basso, Beattie and Bresnahan locomotor rating scale or of motor evoked potentials indicated that motor functional recovery was enhanced; retrograde tracing confirmed that the ascending tract was regenerated and the neural pathway was established; and histological analyses revealed that axon growth and remyelination in the regenerated nerve was promoted. The three-dimensional reconstruction showed that the chitosan conduit loaded with BMSCs significantly reduced the spinal cord cavity volume at the injured site. Taken together, the results collectively suggest that implantation with BMSCs-loaded chitosan conduits may become a promising approach to the repair of spinal cord injury.
引用
收藏
页码:2347 / 2356
页数:10
相关论文
共 41 条
[1]   Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats [J].
Ankeny, DP ;
McTigue, DM ;
Jakeman, LB .
EXPERIMENTAL NEUROLOGY, 2004, 190 (01) :17-31
[2]   Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft [J].
Barry, FP ;
Murphy, JM ;
English, K ;
Mahon, BP .
STEM CELLS AND DEVELOPMENT, 2005, 14 (03) :252-265
[3]   A SENSITIVE AND RELIABLE LOCOMOTOR RATING-SCALE FOR OPEN-FIELD TESTING IN RATS [J].
BASSO, DM ;
BEATTIE, MS ;
BRESNAHAN, JC .
JOURNAL OF NEUROTRAUMA, 1995, 12 (01) :1-21
[4]   Adult NG2+Cells Are Permissive to Neurite Outgrowth and Stabilize Sensory Axons during Macrophage-Induced Axonal Dieback after Spinal Cord Injury [J].
Busch, Sarah A. ;
Horn, Kevin P. ;
Cuascut, Fernando X. ;
Hawthorne, Alicia L. ;
Bai, Lianhua ;
Miller, Robert H. ;
Silver, Jerry .
JOURNAL OF NEUROSCIENCE, 2010, 30 (01) :255-265
[5]   Study of in vivo differentiation of rat bone marrow stromal cells into Schwann cell-like cells [J].
Chen, X ;
Wang, XD ;
Chen, G ;
Lin, WW ;
Yao, J ;
Gu, XS .
MICROSURGERY, 2006, 26 (02) :111-115
[6]   Studies on nerve cell affinity of biodegradable modified chitosan films [J].
Cheng, MY ;
Cao, WL ;
Cao, Y ;
Gong, YD ;
Zhao, NM ;
Zhang, XF .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2003, 14 (10) :1155-1167
[7]   Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury [J].
Cho, Youngnam ;
Shi, Riyi ;
Borgens, Richard B. .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2010, 213 (09) :1513-1520
[8]   Molecular approaches to spinal cord repair [J].
David, S ;
Lacroix, S .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :411-440
[9]   Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery [J].
Gan, Q ;
Wang, T ;
Cochrane, C ;
McCarron, P .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 44 (2-3) :65-73
[10]   In vitro evaluation of the mucoadhesive properties of chitosan microspheres [J].
He, P ;
Davis, SS ;
Illum, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 166 (01) :75-88